Baxter Announces Licensing Agreement for Innocoll’s Gentamicin Surgical Implant in the United States

Baxter Healthcare Corporation today announced a licensing agreement with Innocoll Pharmaceuticals Ltd for exclusive rights to market and distribute the company’s gentamicin surgical implant in the United States